The marketing initiative touts the protein and fiber content of the offerings, which appeals to consumers taking weight-loss ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

New research shows how weight loss meds like Wegovy are reshaping alcohol habits, offering new insights into addiction ...

This year’s top diabetes content focused on pediatric metabolic health, misconceptions about weight loss drugs, and more.

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...

Evidence is mounting that new therapies already used to treat gut diseases, type 2 diabetes, and obesity may help people with alcohol use disorder (AUD).

The German Diabetes Society (DDG) issued a warning concerning a rise in pregnancies among women using injectable medications ...

First-in-class, oral small molecule to prevent weight regain, without need for significant lifestyle modifications — ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

FTC approves Novo Holdings' $16.5B Catalent acquisition. Deal includes selling 3 facilities to Novo Nordisk for $11B, despite ...

Hims & Hers Health, Inc. HIMS has emerged as a transformative player in the personalized healthcare market, showcasing robust ...